Effect of supplementation in treatment of patients with gestational diabetes

Phase 3

• Conditions: Gestational diabetes.; Diabetes mellitus in pregnancy, unspecified; E28.2

• Registration Number: IRCT201612045623N95
• Lead Sponsor: Vice chancellor for research, Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Patients with gestational diabetes
aged 18 to 40 years

Exclusion Criteria

Taking selenium supplements before the intervention
Needing insulin therapy
Placenta abruption
Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Smokers

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TNF-a. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR-RT.

Secondary Outcome Measures

Name	Time	Method
IL-1. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR-RT.;IL-8. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR-RT.;TGF-B. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR-RT.;VEGF. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: PCR-RT.